These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 1689802

  • 21. Macrophage-HIV interaction: viral isolation and target cell tropism.
    Gendelman HE, Baca LM, Husayni H, Turpin JA, Skillman D, Kalter DC, Orenstein JM, Hoover DL, Meltzer MS.
    AIDS; 1990 Mar; 4(3):221-8. PubMed ID: 2112397
    [Abstract] [Full Text] [Related]

  • 22. Muramyl dipeptide inhibits replication of human immunodeficiency virus in vitro.
    Masihi KN, Lange W, Rohde-Schulz B, Chedid L.
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):393-9. PubMed ID: 2111159
    [Abstract] [Full Text] [Related]

  • 23. Altered constitutive and stress-regulated heat shock protein 27 expression in HIV type 1-infected cell lines.
    Brenner BG, Tao Y, Pearson E, Remer I, Wainberg MA.
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):713-7. PubMed ID: 7576931
    [No Abstract] [Full Text] [Related]

  • 24. Dimethyl sulfoxide inhibits human immunodeficiency virus production in vitro.
    Viza D, Aranda-Anzaldo A, Zompetti C, Vich JM.
    Intervirology; 1991 Jun; 32(1):59-64. PubMed ID: 1707866
    [Abstract] [Full Text] [Related]

  • 25. Suppression of HIV-1 reverse transcriptase activity by mycoplasma contamination of cell cultures.
    Vasudevachari MB, Mast TC, Salzman NP.
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):411-6. PubMed ID: 1692726
    [Abstract] [Full Text] [Related]

  • 26. Kinetics of infected cell appearance as a determinant of number of human immunodeficiency virus-1 infectious units.
    Cory JM, Ohlsson-Wilhelm BM, Steck ME, Smithgall MD, Rozday V, Eyster ME, Rapp F.
    AIDS Res Hum Retroviruses; 1989 Feb; 5(1):97-106. PubMed ID: 2497763
    [Abstract] [Full Text] [Related]

  • 27. Saliva can contribute in quick inhibition of HIV infectivity.
    Pourtois M, Binet C, Van Tieghem N, Courtois PR, Vandenabbeele A, Thirty L.
    AIDS; 1991 May; 5(5):598-600. PubMed ID: 1650564
    [No Abstract] [Full Text] [Related]

  • 28. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics.
    Sundqvist VA, Albert J, Ohlsson E, Hinkula J, Fenyö EM, Wahren B.
    J Med Virol; 1989 Nov; 29(3):170-5. PubMed ID: 2482339
    [Abstract] [Full Text] [Related]

  • 29. [Survival of the human immunodeficiency virus (HIV-1) in Triatoma infestans (Klug, 1834)].
    Lowenstein WA, Romaña CA, Ben Fadel F, Pays JF, Veron M, Rouzioux C.
    Bull Soc Pathol Exot; 1992 Nov; 85(4):310-5; discussion 315-6. PubMed ID: 1280179
    [Abstract] [Full Text] [Related]

  • 30. Defective infection of rabbit peripheral blood monocyte cultures with human immunodeficiency virus type 1.
    Tseng CK, Leibowitz J, Sell S.
    AIDS Res Hum Retroviruses; 1994 Mar; 10(3):285-93. PubMed ID: 8018389
    [Abstract] [Full Text] [Related]

  • 31. Characterization of HIV replication complexes early after cell-to-cell infection.
    Karageorgos L, Li P, Burrell C.
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):817-23. PubMed ID: 7504934
    [Abstract] [Full Text] [Related]

  • 32. Analysis of nonproductive human immunodeficiency virus type 1 infection of human fetal dorsal root ganglia glial cells.
    Kunsch C, Wigdahl B.
    Intervirology; 1990 Sep; 31(2-4):147-58. PubMed ID: 1695619
    [Abstract] [Full Text] [Related]

  • 33. Human immunodeficiency virus isolates from asymptomatic homosexual men and from AIDS patients have distinct biologic and genetic properties.
    Balachandran R, Thampatty P, Enrico A, Rinaldo C, Gupta P.
    Virology; 1991 Jan; 180(1):229-38. PubMed ID: 1701946
    [Abstract] [Full Text] [Related]

  • 34. In vitro assays show a dissociation of reverse transcriptase activity and core antigen (p24) production in two HIV-1 isolates from a patient receiving long-term treatment with zidovudine (ZDV).
    Masquelier B, Combeau T, Poveda JD, Delord B, Pellegrin JL, Sallafranque-Andreola ML, Tarrago-Litvak L, Fleury HJ.
    J Acquir Immune Defic Syndr (1988); 1991 Jan; 4(5):499-505. PubMed ID: 1707962
    [Abstract] [Full Text] [Related]

  • 35. MAP 30: a new inhibitor of HIV-1 infection and replication.
    Lee-Huang S, Huang PL, Nara PL, Chen HC, Kung HF, Huang P, Huang HI, Huang PL.
    FEBS Lett; 1990 Oct 15; 272(1-2):12-8. PubMed ID: 1699801
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of core antigen (p24) assay and reverse transcriptase activity for detection of human immunodeficiency virus type 1 replication.
    Land S, Beaton F, McPhee DA, Gust ID.
    J Clin Microbiol; 1989 Mar 15; 27(3):486-9. PubMed ID: 2469698
    [Abstract] [Full Text] [Related]

  • 38. Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus.
    Zhu ZH, Chen SS, Huang AS.
    J Acquir Immune Defic Syndr (1988); 1990 Mar 15; 3(3):215-9. PubMed ID: 2154577
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Inhibition of HIV replication in lymphocyte cultures of virus-positive subjects in the presence of sho-saiko-to, an oriental plant extract.
    Buimovici-Klein E, Mohan V, Lange M, Fenamore E, Inada Y, Cooper LZ.
    Antiviral Res; 1990 Mar 15; 14(4-5):279-86. PubMed ID: 1708225
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.